Eurobio Scientific and Acobiom announce the signature of an exclusive commercial agreement for the distribution of a diagnostic test that predicts response to a treatment for pancreatic cancer
22 nov. 2022 11h45 HE
|
Eurobio Scientific
Eurobio Scientific and Acobiom announce the signature of an exclusive commercial agreement for the distribution of a diagnostic test that predicts response to a treatment for pancreatic cancer CE...
EUROBIO : MISE À DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL 2022
27 oct. 2022 12h00 HE
|
Eurobio Scientific
MISE À DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL 2022 Paris, le 27 octobre 2022 – 18h00 Eurobio Scientific (FR0013240934, ALERS, éligible PEA-PME), groupe français leader dans le diagnostic...
EUROBIO SCIENTIFIC: H1 2022 RESULTS CONTINUED GROWTH OF NON-COVID ACTIVITY
11 oct. 2022 02h00 HE
|
Eurobio Scientific
H1 2022 RESULTS CONTINUED GROWTH OF NON-COVID ACTIVITY • Decisive and strategic move with the acquisitions of GenDx and bmd Belgium• Non-COVID activity increases by...
EUROBIO SCIENTIFIC : RESULTATS S1 2022 CROISSANCE CONTINUE DE L’ACTIVITE HORS COVID
11 oct. 2022 02h00 HE
|
Eurobio Scientific
RESULTATS S1 2022 CROISSANCE CONTINUE DE L’ACTIVITE HORS COVID Avancée stratégique décisive avec les acquisitions de GenDX et bmd BelgiqueActivité hors Covid en augmentation de +5,1 % EBITDA de +26...
EUROBIO SCIENTIFIC FINALIZES THE ACQUISITION OF GENDX, INTERNATIONAL HLA DIAGNOSTICS SPECIALIST
03 oct. 2022 11h50 HE
|
Eurobio Scientific
EUROBIO SCIENTIFIC FINALIZES THE ACQUISITION OF GENDX, INTERNATIONAL HLA DIAGNOSTICS SPECIALIST • Acceleration of strategic plan confirming its positioning as a leader in the molecular...
EUROBIO SCIENTIFIC FINALISE L’ACQUISITION DE GENDX, SPECIALISTE INTERNATIONAL DU DIAGNOSTIC HLA
03 oct. 2022 11h50 HE
|
Eurobio Scientific
EUROBIO SCIENTIFIC FINALISE L’ACQUISITION DE GENDX, SPECIALISTE INTERNATIONAL DU DIAGNOSTIC HLA Accélération du plan stratégique confirmant le positionnement d’Eurobio Scientific en tant que leader...
EUROBIO SCIENTIFIC SIGNS AN AGREEMENT TO ACQUIRE GENDX, INTERNATIONAL HLA DIAGNOSTICS SPECIALIST
17 août 2022 12h00 HE
|
Eurobio Scientific
EUROBIO SCIENTIFIC SIGNS AN AGREEMENT TO ACQUIRE GENDX, INTERNATIONAL HLA DIAGNOSTICS SPECIALIST • Acceleration of strategic plan confirming its positioning as a leader in the molecular...
EUROBIO SCIENTIFIC SIGNE UN ACCORD EN VUE D’ACQUERIR GENDX, SPECIALISTE INTERNATIONAL DU DIAGNOSTIC HLA
17 août 2022 12h00 HE
|
Eurobio Scientific
EUROBIO SCIENTIFIC SIGNE UN ACCORD EN VUE D’ACQUERIR GENDX, SPECIALISTE INTERNATIONAL DU DIAGNOSTIC HLA Accélération de son plan stratégique confirmant son positionnement en tant que leader sur le...
Eurobio Scientific: FIRST HALF TURNOVER OF € 83.6 MILLION MAINTAINED AT A HIGH LEVEL
25 juil. 2022 12h15 HE
|
Eurobio Scientific
FIRST HALF TURNOVER OF € 83.6 MILLION MAINTAINED AT A HIGH LEVEL Growth in non-COVID activity (+5.1%)Limited decline in COVID revenue to €40.6m in a context of sharp reduction in prices and...
Eurobio Scientific : CHIFFRE D’AFFAIRES SEMESTRIEL DE 83,6 M€ MAINTENU A UN NIVEAU ELEVE
25 juil. 2022 12h15 HE
|
Eurobio Scientific
CHIFFRE D’AFFAIRES SEMESTRIEL DE 83,6 M€ MAINTENU A UN NIVEAU ELEVE Progression de l’activité hors-COVID (+5,1%)Recul limité du chiffre d’affaires COVID à 40,6 M€ dans un contexte de forte réduction...